Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women
- Conditions
- HIV Infections
- Interventions
- Dietary Supplement: Multivitamins-Single RDADietary Supplement: Multivitamins-Multiples of RDA
- Registration Number
- NCT00197678
- Lead Sponsor
- Harvard School of Public Health (HSPH)
- Brief Summary
The purpose of this study is to examine effects of daily administration of multivitamin supplements at doses resembling the Recommended Dietary Allowance (RDA) during pregnancy to HIV positive women decreases the risks of low birth weight (\<2500 g), and pre-term birth (\< 37 weeks gestation), compared to multivitamin supplements at doses above the RDA.
- Detailed Description
This is a randomized clinical trial conducted to examine effects of daily administration of multivitamin supplements at doses resembling the Recommended Dietary Allowance (RDA) during pregnancy to HIV positive women decreases the risks of low birth weight (\<2500 g), and pre-term birth (\< 37 weeks gestation), compared to multivitamin supplements at doses above the RDA. All women receive standard prenatal care, including nevirapine for the prevention of mother-to-child transmission of HIV.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 1141
- HIV-positive pregnant women who are between 12 and 27 weeks gestation who intend to stay in Dar es Salaam until delivery.
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Multivitamins-Single RDA Multivitamins-Single RDA Multivitamins at doses resembling a single daily Recommended Dietary Allowance (RDA) Multivitamins-Multiples of RDA Multivitamins-Multiples of RDA Multivitamin supplements at multiples of the Recommended Dietary Allowance (RDA)
- Primary Outcome Measures
Name Time Method Low birthweight (< 2500 g) Delivery Pre-term birth (< 36 weeks gestation) Monthly until the 32nd week of pregnancy, once every 2 weeks from 32nd to 36th week
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Harvard School of Public Health
🇺🇸Boston, Massachusetts, United States